报价延迟最少15分钟:2025/08/29 19:09 EDT
盘后时段
|
||||
|
43.8 
|
|
|
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
43.93
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.43/0.77
|
|
企业价值
2.42B
|
| 资产负债 |
|
每股账面净值
8.90
|
| 现金流量 |
|
现金流量率
0.01
|
| 损益表 |
|
收益
388.54M
|
|
每股收益
7.20
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
报价延迟最少15分钟：2025/08/29 19:09 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America. |
